Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Standard BioTools Inc.

LAB•NASDAQ
Healthcare
Medical - Devices
$1.11
$-0.03(-3.04%)
U.S. Market is Open • 12:27

Standard BioTools Inc. (LAB) Stock Overview

Explore Standard BioTools Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap434.6M
P/E Ratio-3.40
EPS (TTM)$-0.39
ROE-0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$0.92
3 Months$1.18
1 Year Target$0.53

LAB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Standard BioTools Inc. (LAB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 31.82, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.40 and a market capitalization of 434.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.74%
5-Day Change
1.80%
1-Month Change
-25.17%
3-Month Change
-11.72%
6-Month Change
-8.13%
Year-to-Date (YTD) Change
-11.02%
1-Year Change
-16.30%
3-Year Change
-44.33%
5-Year Change
-79.45%
All-Time (Max) Change
-91.94%

Contact Information

https://www.standardbio.com
650 266 6000
2 Tower Place, South San Francisco, CA, 94080

Company Facts

8,140 Employees
IPO DateFeb 10, 2011
CountryUS
Actively Trading

Frequently Asked Questions